# Supplements and nutraceuticals

Rating: Promising — Some human trials, or consistent animal work with a clear mechanism
Type: Guide
Updated: 2026-10-14
Canonical: https://heretic.bio/articles/supplements-and-nutraceuticals.html

> This is a tiered framework: test first, supplement for confirmed deficiencies or increased demand, and insist on third-party quality certification. The top tier has real RCT meta-analyses, including vitamin D3 cutting all-cause mortality 6% across 56 trials and omega-3 cutting MI risk 28% in VITAL, while condition-specific and longevity tiers get progressively thinner. Some popular products are actively harmful, such as high-dose beta-carotene in smokers and iron taken without testing.

> Supplements should fill gaps in an optimal diet, not compensate for a poor one. The supplement industry is largely unregulated and full of overpriced, under-dosed, and sometimes dangerous products. However, a targeted supplement stack based on individual testing and evidence can meaningfully improve health outcomes.

## Critical Framework for Supplementation

### When Supplements Make Sense

  1. **Nutrient deficiency** confirmed by testing (vitamin D, B12, iron, magnesium)
  2. **Increased physiological demand** (pregnancy, intense training, chronic illness)
  3. **Food supply inadequacy** (soil depletion makes some nutrients harder to obtain)
  4. **Therapeutic dosing** for specific conditions (niacin for lipids, berberine for blood sugar)
  5. **Constitutional enhancement** (creatine for muscle, omega-3 for inflammation)



### When Supplements Don't Make Sense

  1. **To "fix" a bad diet** — supplements cannot replicate whole-food matrices
  2. **Based on marketing, not evidence** — most supplement marketing is hype
  3. **"Kitchen sink" approaches** — throwing 30 supplements at a wall
  4. **Without measuring** — don't supplement what you haven't tested
  5. **Expecting drugs-level effects** — supplements are subtle, food-grade interventions



### Quality Matters

  * **Third-party testing:** Look for NSF, USP, GMP, or ConsumerLab certification
  * **Bioavailable forms:** Glycinate > oxide (magnesium), methylcobalamin > cyanocobalamin (B12), ubiquinol > ubiquinone (CoQ10)
  * **Avoid:** Proprietary blends (hiding doses), unnecessary fillers, artificial colors



## Tier 1: Strong Evidence (Most People Should Consider)

### Vitamin D3

  * **Deficiency prevalence:** ~40% of US population; higher in dark-skinned individuals, elderly, northern latitudes
  * **Optimal range:** 40-60 ng/mL (100-150 nmol/L)
  * **Cofactors:** Vitamin K2 (MK-7, 100-200 mcg), magnesium (required for activation)
  * **Evidence:** Immune function, bone health, mood, hormone synthesis
  * **Mortality evidence (2024 update):** Cochrane 2014 meta-analysis of 56 RCTs (n=95,286) — vitamin D3 ↓ all-cause mortality (RR 0.94, 95% CI 0.91–0.98; PMID [24414552](https://pubmed.ncbi.nlm.nih.gov/24414552/)). Zhang 2019 BMJ meta-analysis (50 trials, n=74,655) — vitamin D3 ↓ cancer mortality 15% (RR 0.85, 95% CI 0.74–0.97; PMID [31405892](https://pubmed.ncbi.nlm.nih.gov/31405892/)). 2024 RCT meta-analysis (COVID-19, 19 RCTs, n=2,495) — ↓ all-cause mortality OR 0.72 (95% CI 0.53–0.98; severe COVID OR 0.57, 95% CI 0.35–0.92). Vitamin D2, alfacalcidol, and calcitriol showed no mortality benefit. PMID-summarized in umbrella review (Suzuki 2023, 116 RCTs, n=149,865): respiratory cancer ↓ (RR 0.56), COVID-19 ↓ (RR 0.54), liver cirrhosis ↓ (RR 0.63); no benefit in general healthy, CKD, CVD, sepsis populations.



### Magnesium

  * **Deficiency prevalence:** ~50% of US population gets less than RDA
  * **Why we're deficient:** Soil depletion, water treatment, stress depletes Mg, prescription drugs
  * **Best forms:** Glycinate (sleep/calm), threonate (brain), malate (energy), citrate (bowels)
  * **Functions:** 300+ enzymatic reactions, ATP production, muscle relaxation, sleep, DNA repair
  * **Key evidence:** Rosanoff A et al. 2012, _Nutr Rev_ / _Mg Res_ — "Essential Role of Magnesium in Human Health" (PMID [22389183](https://pubmed.ncbi.nlm.nih.gov/22389183/)) — foundational review of deficiency burden and metabolic sequelae. Fang X et al. 2016, _BMC Med_ — meta-analysis of 40 prospective cohort studies; ↑ dietary magnesium ↓ risk of stroke, heart failure, T2D, and all-cause mortality (PMID [26912566](https://pubmed.ncbi.nlm.nih.gov/26912566/)). Veronese N et al. 2019, _Eur J Clin Nutr_ — meta-analysis: magnesium supplementation ↓ systolic BP (−2.00 mmHg) and ↑ flow-mediated dilation in hypertensive/older subjects.



### Omega-3 Fatty Acids (EPA/DHA)

  * **Rationale:** [Omega-6 excess](seed-oils-and-inflammation.html) in modern diet requires omega-3 compensation
  * **Sources:** Fish oil, algae oil (vegan), krill oil
  * **Quality:** Must be third-party tested for oxidation, heavy metals
  * **Evidence:** Cardiovascular protection, anti-inflammatory, brain health, mood
  * **Key evidence:** VITAL trial (Manson JE et al. 2019, _NEJM_ 380:33–44, PMID [30415637](https://pubmed.ncbi.nlm.nih.gov/30415637/); n=25,871) — omega-3 ↓ MI risk 28% (HR 0.72, 95% CI 0.59–0.90), with stronger effect in low fish-intake subgroup. REDUCE-IT trial (Bhatt DL et al. 2019, _NEJM_ 380:11–22, PMID [30415628](https://pubmed.ncbi.nlm.nih.gov/30415628/); n=8,179) — icosapent ethyl 4g/day ↓ CV events 25% (HR 0.75, 95% CI 0.68–0.83); mineral oil placebo caveat. STRENGTH trial (Nicholls SJ et al. 2020, _JAMA_ 324:2268–2280, PMID [33190147](https://pubmed.ncbi.nlm.nih.gov/33190147/)) — high-dose EPA+DHA + mineral oil placebo, no benefit, possibly pro-arrhythmic in atrial fibrillation subgroup. Mechanism + dose-response differences between trials are key.



### Creatine

  * **Not just for bodybuilders:** Cognitive benefits well-established; neuroprotection
  * **Form:** Creatine monohydrate (cheapest and best-studied; all other forms are inferior)
  * **Evidence:** Strength, power, brain energy, traumatic brain injury recovery, aging
  * **Deep dive:** [Creatine Monohydrate - Muscle, Brain, and Bone Evidence](creatine-monohydrate-muscle-brain-and-bone-evidence.html) — full evidence taxonomy (2024-26 cognition/depression/menopause trials), dosing protocols, safety analysis



## Tier 2: Condition-Specific Evidence

### Metabolic Health

Supplement | Use Case | Evidence  
---|---|---  
**Berberine** | Blood sugar, insulin sensitivity (comparable to metformin) | Strong  
**Alpha-lipoic acid** | Insulin sensitizer, neuropathy, antioxidant | Moderate-strong  
**Chromium picolinate** | Glucose metabolism | Moderate  
**Inositol** | PCOS, insulin signaling, mood | Strong (PCOS)  
  
### Anti-Inflammatory

Supplement | Use Case | Evidence  
---|---|---  
**Curcumin (with piperine/liposomal)** | Systemic inflammation, joint pain | Strong  
**Boswellia serrata** | Joint inflammation, gut inflammation | Moderate  
**Quercetin** | Allergies, [senolytic](senolytics.html), antioxidant | Moderate  
**Ginger** | Digestive, anti-inflammatory | Moderate  
  
### Cognitive/Nootropic

Supplement | Use Case | Evidence  
---|---|---  
**Lion's Mane** | NGF stimulation, cognitive support | Moderate (see [Lion's Mane and Mushroom Nootropics](lions-mane-and-mushroom-nootropics.html))  
**L-theanine** | Calm focus, pairs with caffeine | Moderate  
**Phosphatidylserine** | Memory, stress response | Moderate  
**Bacopa monnieri** | Memory consolidation | Moderate  
  
### Sleep and Recovery

Supplement | Use Case  
---|---  
**Magnesium glycinate** | [Sleep quality](sleep-optimization.html)  
**Glycine** | Core temperature, sleep quality  
**GABA** | Relaxation (blood-brain barrier penetration debated)  
**5-HTP** | Serotonin precursor (caution with SSRIs)  
  
## Tier 3: Emerging/Advanced

### Longevity-Related

  * **NAD+ precursors (NMN, NR):** See [NAD+ and Sirtuin Activators](nad-and-sirtuin-activators.html)
  * **Urolithin A:** Mitophagy induction; pomegranate-derived
  * **Spermidine:** [Autophagy](autophagy.html) inducer; found in wheat germ, aged cheese
  * **Fisetin:** [Senolytic](senolytics.html) compound; found in strawberries
  * **Resveratrol:** SIRT1 activator; bioavailability issues
  * **Alpha-Ketoglutarate (CaAKG):** See [Alpha-Ketoglutarate (AKG) - The Metabolic Longevity Molecule](alpha-ketoglutarate-akg-the-metabolic-longevity-molecule.html) — TCA cycle metabolite; ~12% mouse lifespan extension; top supplement for biological age reduction in 2026 observational study of 84 compounds (PMID [42166733](https://pubmed.ncbi.nlm.nih.gov/42166733/))



## Supplements to Avoid or Approach with Caution

Supplement | Issue  
---|---  
**High-dose beta-carotene** | Increased lung cancer risk in smokers  
**High-dose vitamin E** | Increased all-cause mortality in meta-analyses  
**Calcium carbonate alone** | Cardiovascular risk without K2; poor absorption  
**Iron (without testing)** | Iron overload is as dangerous as deficiency  
**St. John's Wort** | Massive drug interactions (CYP450 inducer)  
**Kava** | Hepatotoxicity risk  
**High-dose B6** | Peripheral neuropathy with chronic high doses  
**Most "testosterone boosters"** | Herbal blends with no evidence of T elevation

## Sources

1. Bjelakovic G et al. (2014). Vitamin D supplementation for prevention of mortality in adults. Cochrane Database Syst Rev CD007470. PMID 24414552 — 56 RCTs, n=95,286; vitamin D3 ↓ all-cause mortality (RR 0.94). (PubMed 24414552)
2. Zhang Y et al. (2019). Association between vitamin D supplementation and mortality: systematic review and meta-analysis. BMJ 366:l4673. PMID 31405892 — 50 RCTs, n=74,655; vitamin D3 ↓ cancer mortality 15% (RR 0.85). (PubMed 31405892)
3. PubMed 22389183 (PubMed 22389183)
4. Fang X et al. (2016). Dietary magnesium intake and the risk of cardiovascular disease, type 2 diabetes, and all-cause mortality: a dose-response meta-analysis of prospective cohort studies. BMC Med 14:210. PMID 26912566 — 40 prospective cohorts. (PubMed 26912566)
5. Manson JE et al. (VITAL trial). (2019). Marine n-3 fatty acids and prevention of cardiovascular disease and cancer. NEJM 380:33–44. PMID 30415637 — n=25,871; omega-3 ↓ MI risk 28%. (PubMed 30415637)
6. Bhatt DL et al. (REDUCE-IT). (2019). Cardiovascular risk reduction with icosapent ethyl for hypertriglyceridemia. NEJM 380:11–22. PMID 30415628 — n=8,179; icosapent 4g/day ↓ CV events 25%. (PubMed 30415628)
7. Nicholls SJ et al. (STRENGTH). (2020). Effect of high-dose omega-3 fatty acids vs corn oil on major adverse cardiovascular events in patients at high cardiovascular risk: the STRENGTH randomized clinical trial. JAMA 324:2268–2280. PMID 33190147 — null result, AF risk signal. (PubMed 33190147)
8. PubMed 42166733 (PubMed 42166733)
9. Rosanoff A, Weaver CM, Rude RK. (2012). Suboptimal magnesium status in the United States: are the health consequences underestimated? Nutr Rev 70(3):153–164. PMID 22389157 — foundational Mg deficiency burden review. (PubMed 22389157)
10. Suzuki M et al. (2023). The effects of vitamin D on all-cause mortality in different diseases: an evidence-map and umbrella review of 116 randomized controlled trials. Front Nutr 10:1132528. PMC10325578 — umbrella review; benefits limited to respiratory cancer, COVID-19, liver disease subgroups. (PMC10325578)